Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outpatient Antibiotic Prescribing for Uncomplicated Diverticulitis in Veterans Affairs Facilities: A Retrospective Cohort Study.

Annals of internal medicine·2026
Same author

Recommendations made and accepted by a telehealth-enabled Antimicrobial Stewardship program implemented at rural veterans affairs medical centers.

Infection control and hospital epidemiology·2026
Same author

Accuracy of Point-of-Care Transdermal GFR Methodology.

Kidney international reports·2026
Same author

Genomic characterization and sub-clustering of Escherichia coli clonal complex 38 reveal host associated genetic markers.

Communications medicine·2026
Same author

Dissemination and Implementation of a Telehealth-Enabled Program for Providing Infectious Disease Expertise in Rural Settings.

Open forum infectious diseases·2025
Same author

Characterization of human <i>Escherichia coli</i> isolate DP51 using whole genome sequencing.

Microbiology resource announcements·2025

Related Experiment Video

Updated: Jul 4, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

Antimicrobial urinary catheters: a systematic review.

Dimitri M Drekonja1, Michael A Kuskowski, Timothy J Wilt

  • 1Infectious Diseases, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USA. drek0002@umn.edu

Expert Review of Medical Devices
|June 25, 2008
PubMed
Summary

Antimicrobial-coated catheters help prevent catheter-associated bacteriuria/funguria (CABF) but lack proven clinical benefits. Further research is needed to confirm their effectiveness and develop better urinary drainage solutions.

More Related Videos

A Catheter-Related Candida albicans Infection Model in Mouse
03:24

A Catheter-Related Candida albicans Infection Model in Mouse

Published on: March 22, 2024

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

Related Experiment Videos

Last Updated: Jul 4, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

A Catheter-Related Candida albicans Infection Model in Mouse
03:24

A Catheter-Related Candida albicans Infection Model in Mouse

Published on: March 22, 2024

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

Area of Science:

  • Infectious Diseases
  • Medical Devices
  • Urology

Background:

  • Catheter-associated urinary tract infection (CAUTI) is common, with catheter-associated bacteriuria/funguria (CABF) potentially leading to severe outcomes like urosepsis.
  • Antimicrobial-coated catheters are used globally to prevent CAUTI, but their clinical efficacy remains uncertain.
  • No trials have directly compared the effectiveness of different antimicrobial-coated catheters.

Purpose of the Study:

  • To systematically review and evaluate existing evidence on the clinical efficacy of antimicrobial-coated catheters.
  • To address uncertainties regarding the effectiveness of antimicrobial-coated catheters in preventing CABF and improving clinical outcomes.
  • To identify gaps in current research and suggest future directions for developing better bladder drainage methods.

Main Methods:

  • Systematic review of randomized and quasi-randomized clinical trials.
  • Evaluation of evidence on the incidence of CABF with antimicrobial-coated catheters.
  • Assessment of clinical benefits and comparison of different antimicrobial-coated catheter types.

Main Results:

  • Consistent evidence shows antimicrobial-coated catheters reduce CABF incidence during short-term use.
  • No studies demonstrated a significant clinical benefit associated with using these catheters.
  • There is a lack of direct comparative trials evaluating the efficacy of various marketed antimicrobial-coated catheters.

Conclusions:

  • Antimicrobial-coated catheters appear effective in preventing CABF but do not offer proven clinical advantages.
  • Further research, including randomized trials with clinically relevant endpoints, is necessary.
  • Development of improved, safer bladder drainage mechanisms is recommended.